The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest

Current Opinion in HIV and AIDS

Volumn 7, Issue 2, 2012, Pages 187-194

  Sharifi, Hamayun J ^a   Furuya, Andrea M ^a   De Noronha, Carlos M C ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

HIV; SAMHD1; SIV; Vpr; Vpx

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; PROTEIN SAMHD1; PROTEIN VPX; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE CRL4; UNCLASSIFIED DRUG; URACIL N GLYCOSYLASE 2; VIF PROTEIN; VIRUS PROTEIN; VPR PROTEIN;

CELL CYCLE ARREST; CELL INTERACTION; CELL LINEAGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; UPREGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE CHECKPOINTS; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MONOMERIC GTP-BINDING PROTEINS; UBIQUITIN-PROTEIN LIGASE COMPLEXES; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84857335654     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32835049e0     Document Type: Review

References (63)

1. Derby N, Martinelli E, Robbiani M. Myeloid dendritic cells in HIV-1 infection. Curr Opin HIV AIDS 2011; 6:379-384.
2. Barratt-Boyes SM, Brown KN, Melhem N, et al. Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model. Immunol Res 2006; 36:265-274. (Pubitemid 46402782)
3. Barratt-Boyes SM, Wijewardana V. A divergent myeloid dendritic cell response at virus set-point predicts disease outcome in SIV-infected rhesus macaques. J Med Primatol 2011; 40:206-213.
4. Geng W, Fan X, Diao Y, et al. Rapid disease progression in HIV-1-infected men who have sex with men is negatively correlated with peripheral plasmacytoid dendritic cell counts at the early stage of primary infection. J Clin Immunol 2011; 31:882-890.
5. Dillon SM, Friedlander LJ, Rogers LM, et al. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3 frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study. J Virol 2011; 85:397-409.
6. Yonkers NL, Rodriguez B, Asaad R, et al. Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells. PLoS ONE 2011; 6:e23884.
7. Benlahrech A, Gotch F, Kelleher P, Patterson S. Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients. PLoS ONE 2011; 6:e17525.
8. Harman AN, Wilkinson J, Bye CR, et al. HIV induces maturation of monocytederived dendritic cells and Langerhans cells. J Immunol 2006; 177:7103-7113. (Pubitemid 44715078)
9. McDonald D, Wu L, Bohks SM, et al. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003; 300:1295-1297. (Pubitemid 36618241)
10. Zhang L, Jiang Q, Li G, et al. Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2/gamma C/mice in vivo. Blood 2011; 117: 6184-6192.
11. Merbah M, Introini A, Fitzgerald W, et al. Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection. Am J Reprod Immunol 2011; 65:268-278.
12. Ganor Y, Bomsel M. HIV-1 transmission in the male genital tract. Am J Reprod Immunol 2011; 65:284-291.
13. Oyaizu N, McCloskey TW, Coronesi M, et al. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 1993; 82:3392-3400. (Pubitemid 23356712)
14. Zheng L, Fisher G, Miller RE, et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995; 377:348-351.
15. Herbein G, Gras G, Khan KA, Abbas W. Macrophage signaling in HIV-1 infection. Retrovirology 2010; 7:34.
16. Wen X, Duus KM, Friedrich TD, de Noronha CM. The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor. J Biol Chem 2007; 282:27046-27057.
17. Belzile JP, Duisit G, Rougeau N, et al. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4A(VPRBP) E3 ubiquitin ligase. PLoS Pathog 2007; 3:e85.
18. Tan L, Ehrlich E, Yu XF. DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest. J Virol 2007; 81:10822-10830. (Pubitemid 47463356)
19. Hrecka K, Gierszewska M, Srivastava S, et al. Lentiviral Vpr usurps Cul4-DDB1VprBP E3 ubiquitin ligase to modulate cell cycle. Proc Natl Acad Sci U S A 2007; 104:11778-11783. (Pubitemid 47175089)
20. DeHart JL, Zimmerman ES, Ardon O, et al. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. Virol J 2007; 4:57.
21. Schrofelbauer B, Hakata Y, Landau NR. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc Natl Acad Sci U S A 2007; 104:4130-4135. (Pubitemid 47181590)
22. Le Rouzic E, Belaidouni N, Estrabaud E, et al. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle (Georgetown, Tex) 2007; 6:182-188. (Pubitemid 46232499)
23. Roshal M, Kim B, Zhu Y, et al. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J Biol Chem 2003; 278:25879-25886. (Pubitemid 36835349)
24. Goh WC, Rogel ME, Kinsey CM, et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med 1998; 4:65-71. (Pubitemid 28133081)
25. Richard J, Sindhu S, Pham TN, et al. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 2010; 115:1354-1363.
26. Ward J, Davis Z, DeHart J, et al. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog 2009; 5:e1000613.
27. Jenkins Y, McEntee M, Weis K, Greene WC. Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J Cell Biol 1998; 143:875-885. (Pubitemid 28547389)
28. Heinzinger NK, Bukinsky MI, Haggerty SA, et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A 1994; 91:7311-7315. (Pubitemid 24226853)
29. Bukrinsky MI, Sharova N, Dempsey MP, et al. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A 1992; 89:6580-6584.
30. Popov S, Rexach M, Ratner L, et al. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J Biol Chem 1998; 273:13347-13352. (Pubitemid 28246910)
31. Popov S, Rexach M, Zybarth G, et al. Viral protein R regulates nuclear import of the HIV-1 preintegration complex. EMBO J 1998; 17:909-917. (Pubitemid 28077645)
32. Subbramanian RA, Kessous-Elbaz A, Lodge R, et al. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J Exp Med 1998; 187:1103-1111. (Pubitemid 28176410)
33. Yamashita M, Emerman M. Retroviral infection of nondividing cells: old and new perspectives. Virology 2006; 344:88-93. (Pubitemid 41814454)
34. Riviere L, Darlix JL, Cimarelli A. Analysis of the viral elements required in the nuclear import of HIV-1 DNA. J Virol 2010; 84:729-739.
35. Yamashita M, Emerman M. The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog 2005; 1:e18.
36. Srivastava S, Swanson SK, Manel N, et al. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog 2008; 4:e1000059.
37. Sharova N, Wu Y, Zhu X, et al. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog 2008; 4:e1000057.
38. Kaushik R, Zhu X, Stranska R, et al. A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe 2009; 6:68-80.
39. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995; 206:935-944.
40. Fletcher TM 3rd, Brichacek B, Sharova N, et al. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J 1996; 15:6155-6165. (Pubitemid 26397887)
41. Tristem M, Marshall C, Karpas A, Hill F. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J 1992; 11:3405-3412.
42. Hrecka K, Hao C, Gierszewska M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011; 474:658-661. This paper identifiesSAMHD1as a novel antiviral factor that inhibits HIV-1monocytederived macrophages and links this activity to the CRL4DCAF1 ubiquitin ligase complex.
43. Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature. 2011; 474:654-657. This paper identifies SAMHD1 as a novel antiviral factor that inhibits HIV-1 in monocyte-derived dendritic cells.
44. Powell RD, Holland PJ, Hollis T, Perrino FW. The Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem 2011; 286:43596-43600.
45. Goldstone DC, Ennis-Adeniran V, Hedden JJ, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011; 480:379-382.
46. Pertel T, Reinhard C, Luban J. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Retrovirology 2011; 8:49.
47. This work revealed a LPS-/IFN-b-inducible restriction in monocyte-derived dendritic cells that has characteristics distinct from SAMHD1 restriction. 47. Kokkotou EG, Sankale JL, Mani I, et al. In vitro correlates of HIV-2-mediated HIV-1 protection. Proc Natl Acad Sci U S A 2000; 97:6797-6802. (Pubitemid 30412794)
48. Schrofelbauer B, Yu Q, Zeitlin SG, Landau NR. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J Virol 2005; 79:10978-10987. (Pubitemid 41170639)
49. Pham TN, Richard J, Gerard FC, et al. Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R (Vpr) from HIV-1 primary isolates. J Virol 2011; 85:12254-12261. This publication extended previous work showing that Vpr can trigger cell surface expression of NK-cell ligands by demonstrating that this phenotype is conserved among Vpr from various groups and clades.
50. Levy DN, Refaeli Y, Weiner DB. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J Virol 1995; 69:1243-1252.
51. Norman JM, Mashiba M, McNamara LA, et al. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat Immunol 2011; 12:975-983. This study demonstrated the interplay among various HIV and host proteins in modulating the cell surface expression of NK-cell ligands in HIV-1 infected cells.
52. Fenard D, Houzet L, Bernard E, et al. Uracil DNA glycosylase 2 negatively regulates HIV-1 LTR transcription. Nucleic Acids Res 2009; 37:6008-6018.
53. Gibbs JS, Lackner AA, Lang SM, et al. Progression to AIDS in the absence of a gene for vpr or vpx. J Virol 1995; 69:2378-2383.
54. Hirsch VM, Sharkey ME, Brown CR, et al. Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med 1998; 4:1401-1408. (Pubitemid 28553463)
55. Muthumani K, Bagarazzi M, Conway D, et al. Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques. J Med Primatol 2002; 31:179-185.
56. Muthumani K, Hwang DS, Dayes NS, et al. The HIV-1 accessory gene vpr can inhibit antigen-specific immune function. DNA and cell biology 2002; 21:689-695.
57. Silvestri G, Sodora DL, Koup RA, et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003; 18:441-452. (Pubitemid 36351522)
58. Sumpter B, Dunham R, Gordon S, et al. Correlates of preserved CD4 T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis. J Immunol 2007; 178:1680-1691. (Pubitemid 46154640)
59. Lederer S, Favre D, Walters KA, et al. Transcriptional profiling in pathogenic and nonpathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog 2009; 5:e1000296.
60. Harris LD, Tabb B, Sodora DL, et al. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 2010; 84:7886-7891.
61. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-870. (Pubitemid 29159331)
62. Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 2006; 12:289-295. (Pubitemid 43355074)
63. Arhel N, Lehmann M, Clauss K, et al. The inability to disrupt the immunological synapse between infected human T cells and APCs distinguishes HIV-1 from most other primate lentiviruses. J Clin Invest 2009; 119:2965-2975.